Loading...
Dernières publications
-
Katarzyna Grychowska, Uriel López-Sánchez, Mathieu Vitalis, Geoffrey Canet, Grzegorz Satała, et al.. Superiority of the Triple-Acting 5-HT 6 R/5-HT 3 R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT 6 R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats. Journal of Medicinal Chemistry, 2023, 66 (21), pp.14928-14947. ⟨10.1021/acs.jmedchem.3c01482⟩. ⟨hal-04235140⟩
-
David T Valenta, Nicolas Ogier, Gary Bradshaw, Audrey S Black, David J Bonnet, et al.. Atheroprotective Potential of Macrophage-Derived Phospholipid Transfer Protein in Low-Density Lipoprotein Receptor-Deficient Mice Is Overcome by Apolipoprotein AI Overexpression. Arteriosclerosis, Thrombosis, and Vascular Biology, 2023, 26 (7), pp.1572 - 1578. ⟨10.1161/01.atv.0000225700.43836.ae⟩. ⟨hal-04203243⟩
-
Sophie Sakkaki, Noemie Cresto, Raphaël Chancel, Maé Jaulmes, Emma Zub, et al.. Dual-Hit: Glyphosate exposure at NOAEL level negatively impacts birth and glia-behavioural measures in heterozygous shank3 mutants. Environment International, 2023, 180, pp.108201. ⟨10.1016/j.envint.2023.108201⟩. ⟨hal-04222342⟩
-
Jennifer Hua, Elvira Garcia de Paco, Nathalie Linck, Tangui Maurice, Catherine Desrumaux, et al.. Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer’s disease. Cellular and Molecular Life Sciences, 2023, 80 (5), pp.138. ⟨10.1007/s00018-023-04784-x⟩. ⟨hal-04094016⟩
-
Mattia Difrancesco, Manon Marrot, Eleonora Torre, Pietro Mesirca, Romain Davaze, et al.. Characterization of sinoatrial automaticity in Microcebus murinus to study the effect of aging on cardiac activity and the correlation with longevity. Scientific Reports, 2023, 13 (1), pp.3054. ⟨10.1038/s41598-023-29723-5⟩. ⟨hal-04010411⟩
-
Braham Mezghrani, Lamiaa M.A. Ali, Nicolas Cubedo, Mireille Rossel, Peter Hesemann, et al.. Periodic mesoporous ionosilica nanoparticles for dual cancer therapy: Two-photon excitation siRNA gene silencing in cells and photodynamic therapy in zebrafish embryos. International Journal of Pharmaceutics, 2023, 641, pp.123083. ⟨10.1016/j.ijpharm.2023.123083⟩. ⟨hal-04121650⟩
Collaborations MMDN
Mots clés
Amyloid fibril
80 and over
Amyotrophic lateral sclerosis
Dementia
BDNF
Hsp90
Phospholipid transfer protein
Deep brain stimulation
Europe
Detection
Glucocorticoids
Microglia
Centenarians
Neurodegeneration
Ca2+ oscillations
Glial cells
Amyloid
Rat
Rodent
Huntington’s disease
Mitochondria
Ca2+ signalling
Proliferation
Calcium
Belgium
Neuroprotection
Healthy life years
Sigma-1 receptor
Epidemiology
Lemur
Mouse lemur
Amyloid-β
Amyloid toxicity
Dietary indices
Mortality
Hypothalamus
Vasopressin
Aβ25-35
Cochlea
Frail elderly
ER stress
Transgenic rats
Learning and memory
Alzheimer's disease
Aging
Disability
Microcebus murinus
Histology
HPA axis
Magnetic resonance imaging
Atherosclerosis
Cognitive impairment
Drosophila
Depressive symptoms
Stem cells
Animals
Primate
Aged
ACETYLCHOLINESTERASE
Astrocytes
MRI
Amyloid-β peptide
Butyrylcholinesterase
Behavior
Depression
Human brain
IN-VITRO
Glial scar
Acetylcholinesterase
Human
Atomic force microscopy AFM
High pressure
Aggregation
Neurodegenerative diseases
Docosahexaenoic acid
Brain
France
Alternative Healthy Eating Index
Oxytocin
Genetics
Glutamate
Mice
Neurons
Spinal cord injury SCI
Humans
Brain mapping
Neuroinflammation
Neuroscience
GSK-3β
Chronic subdural hematoma
Zebrafish
Functional MRI
Primates
Infection
Health expectancy
Lipoproteins
Prion
Oxidative stress
Tauopathies
Spinal cord injury